FDA Adverse Event Malfunction Summary report: N

UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM

MDR report key: 2161004 · Received June 17, 2011

Report

Report Number
2122870-2011-01892
Event Type
Malfunction
Date Received
June 17, 2011
Date of Event
December 9, 2008
Report Date
December 9, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
JJE
PMA / PMN Number
K023764
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER (FSE) WAS ON SITE ON (B)(4) 2008 TO INVESTIGATE THE EVENT. THE FSE RAN HIGH SENSITIVITY SYSTEM CHECK THAT PASSED SPECS. ALSO, THE FSE PERFORMED A CARRYOVER TEST THAT FAILED SPECS. THE FSE CLEANED THE WASH STATION AND RAN THE CARRYOVER TESTED AGAIN AND IT FAILED SPECS. THE FSE REPLACED THE SAMPLE PIPETTOR AND PERFORMED ALIGNMENTS FOR THE PIPETTOR. THEN REPEATED THE CARRYOVER TESTING AND IT PASSED SPECS. CALIBRATIONS WERE PERFORMED BY THE FSE AND THE QC WAS WITHIN SPECS. NO DEFINITIVE ROOT CAUSE COULD BE DETERMINED FOR THIS EVENT. THIS IS TWO OF TWO REPORTS RELATED TO THREE PT EVENTS ASSOCIATED WITH A SINGLE MALFUNCTION REPORT OCCURRING ON TWO DIFFERENT DAYS. SEE REFERENCE MDR NUMBERS: 2122870-2011-01891 FOR ALL RELATED EVENTS. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS CONDUCTED BETWEEN (B)(4) 2008 TO (B)(4) 2010 FOR ADD'L REPORTABLE EVENTS.

Description of Event or Problem · 1

THE CUSTOMER CONTACTED BECKMAN COULTER, INC. (BCI) IN REGARDS TO ERRONEOUSLY ELEVATED ACCUTNI (TROPONIN) RESULTS OBTAINED FROM A UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM FOR THREE PTS. THE CUSTOMER RE-RAN THE SAMPLES ON A DIFFERENT INSTRUMENT AND THE RESULTS WERE WITHIN NORMAL REFERENCE RANGE. THE CUSTOMER INDICATED THAT THEY HAVE REFLEX CONDITIONS SETUP ON THE SYSTEM THAT ANY A TNI RESULTS THAT IS >0.06 WILL AUTOMATICALLY BE REPEATED. THE CUSTOMER ALSO INDICATED THAT FOUR LEVELS OF QUALITY CONTROLS (QC) ARE RUN THREE TIMES A DAY. QC WAS WITHIN SPECS BEFORE AND AFTER THE EVENT. THE INITIAL ERRONEOUSLY ELEVATED RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY. THERE ARE NO REPORTS OF ANY ADVERSE PT CONSEQUENCES OR CHANGE TO THE PT'S TREATMENT. THERE ARE NO INDICATIONS OF ANY MEDICAL INTERVENTION TO PREVENT OR PRECLUDE ANY ADVERSE PT EVENT.

Additional Manufacturer Narrative · 2

THE FIELD SERVICE ENGINEER (FSE) WAS ON SITE ON (B)(4) 2008 TO INVESTIGATE THE EVENT. THE FSE RAN HIGH SENSITIVITY SYSTEM CHECK THAT PASSED SPECS. ALSO, THE FSE PERFORMED A CARRYOVER TEST THAT FAILED SPECS. THE FSE CLEANED THE WASH STATION AND RAN THE CARRYOVER TESTED AGAIN AND IT FAILED SPECS. THE FSE REPLACED THE SAMPLE PIPETTOR AND PERFORMED ALIGNMENTS FOR THE PIPETTOR. THEN REPEATED THE CARRYOVER TESTING AND IT PASSED SPECS. CALIBRATIONS WERE PERFORMED BY THE FSE AND THE QC WAS WITHIN SPECS. NO DEFINITIVE ROOT CAUSE COULD BE DETERMINED FOR THIS EVENT. THIS IS TWO OF TWO REPORTS RELATED TO THREE PT EVENTS ASSOCIATED WITH A SINGLE MALFUNCTION REPORT OCCURRING ON TWO DIFFERENT DAYS. SEE REFERENCE MDR NUMBERS: 2122870-2011-01891 FOR ALL RELATED EVENTS. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS CONDUCTED BETWEEN (B)(4) 2008 TO (B)(4) 2010 FOR ADD'L REPORTABLE EVENTS.

Description of Event or Problem · 2

THE CUSTOMER CONTACTED BECKMAN COULTER, INC. (BCI) IN REGARDS TO ERRONEOUSLY ELEVATED ACCUTNI (TROPONIN) RESULTS OBTAINED FROM A UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM FOR THREE PTS. THE CUSTOMER RE-RAN THE SAMPLES ON A DIFFERENT INSTRUMENT AND THE RESULTS WERE WITHIN NORMAL REFERENCE RANGE. THE CUSTOMER INDICATED THAT THEY HAVE REFLEX CONDITIONS SETUP ON THE SYSTEM THAT ANY A TNI RESULTS THAT IS >0.06 WILL AUTOMATICALLY BE REPEATED. THE CUSTOMER ALSO INDICATED THAT FOUR LEVELS OF QUALITY CONTROLS (QC) ARE RUN THREE TIMES A DAY. QC WAS WITHIN SPECS BEFORE AND AFTER THE EVENT. THE INITIAL ERRONEOUSLY ELEVATED RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY. THERE ARE NO REPORTS OF ANY ADVERSE PT CONSEQUENCES OR CHANGE TO THE PT'S TREATMENT. THERE ARE NO INDICATIONS OF ANY MEDICAL INTERVENTION TO PREVENT OR PRECLUDE ANY ADVERSE PT EVENT.

Additional Manufacturer Narrative · 3

THE FIELD SERVICE ENGINEER (FSE) WAS ON SITE ON (B)(4) 2008 TO INVESTIGATE THE EVENT. THE FSE RAN HIGH SENSITIVITY SYSTEM CHECK THAT PASSED SPECS. ALSO, THE FSE PERFORMED A CARRYOVER TEST THAT FAILED SPECS. THE FSE CLEANED THE WASH STATION AND RAN THE CARRYOVER TESTED AGAIN AND IT FAILED SPECS. THE FSE REPLACED THE SAMPLE PIPETTOR AND PERFORMED ALIGNMENTS FOR THE PIPETTOR. THEN REPEATED THE CARRYOVER TESTING AND IT PASSED SPECS. CALIBRATIONS WERE PERFORMED BY THE FSE AND THE QC WAS WITHIN SPECS. NO DEFINITIVE ROOT CAUSE COULD BE DETERMINED FOR THIS EVENT. THIS IS TWO OF TWO REPORTS RELATED TO THREE PT EVENTS ASSOCIATED WITH A SINGLE MALFUNCTION REPORT OCCURRING ON TWO DIFFERENT DAYS. SEE REFERENCE MDR NUMBERS: 2122870-2011-01891 FOR ALL RELATED EVENTS. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS CONDUCTED BETWEEN (B)(4) 2008 TO (B)(4) 2010 FOR ADD'L REPORTABLE EVENTS.

Description of Event or Problem · 3

THE CUSTOMER CONTACTED BECKMAN COULTER, INC. (BCI) IN REGARDS TO ERRONEOUSLY ELEVATED ACCUTNI (TROPONIN) RESULTS OBTAINED FROM A UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM FOR THREE PTS. THE CUSTOMER RE-RAN THE SAMPLES ON A DIFFERENT INSTRUMENT AND THE RESULTS WERE WITHIN NORMAL REFERENCE RANGE. THE CUSTOMER INDICATED THAT THEY HAVE REFLEX CONDITIONS SETUP ON THE SYSTEM THAT ANY A TNI RESULTS THAT IS >0.06 WILL AUTOMATICALLY BE REPEATED. THE CUSTOMER ALSO INDICATED THAT FOUR LEVELS OF QUALITY CONTROLS (QC) ARE RUN THREE TIMES A DAY. QC WAS WITHIN SPECS BEFORE AND AFTER THE EVENT. THE INITIAL ERRONEOUSLY ELEVATED RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY. THERE ARE NO REPORTS OF ANY ADVERSE PT CONSEQUENCES OR CHANGE TO THE PT'S TREATMENT. THERE ARE NO INDICATIONS OF ANY MEDICAL INTERVENTION TO PREVENT OR PRECLUDE ANY ADVERSE PT EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM JJE BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 81 YR ACCESS ACCUTNI
2 76 YR ACCESS ACCUTNI
3 91 YR ACCESS ACCUTNI